- Home
- HURC vs CRDL Comparison
HURC vs CRDL Comparison
Compare HURC & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURC
- CRDL
- Stock Information
- Founded
- HURC 1968
- CRDL 2017
- Country
- HURC United States
- CRDL Canada
- Employees
- HURC N/A
- CRDL N/A
- Industry
- HURC Industrial Machinery/Components
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HURC Industrials
- CRDL Health Care
- Exchange
- HURC Nasdaq
- CRDL Nasdaq
- Market Cap
- HURC 125.1M
- CRDL 126.5M
- IPO Year
- HURC N/A
- CRDL N/A
- Fundamental
- Price
- HURC $17.65
- CRDL $1.05
- Analyst Decision
- HURC
- CRDL Strong Buy
- Analyst Count
- HURC 0
- CRDL 2
- Target Price
- HURC N/A
- CRDL $9.00
- AVG Volume (30 Days)
- HURC 27.2K
- CRDL 1.2M
- Earning Date
- HURC 09-05-2025
- CRDL 08-14-2025
- Dividend Yield
- HURC N/A
- CRDL N/A
- EPS Growth
- HURC N/A
- CRDL N/A
- EPS
- HURC N/A
- CRDL N/A
- Revenue
- HURC $186,789,000.00
- CRDL N/A
- Revenue This Year
- HURC N/A
- CRDL N/A
- Revenue Next Year
- HURC N/A
- CRDL N/A
- P/E Ratio
- HURC N/A
- CRDL N/A
- Revenue Growth
- HURC N/A
- CRDL N/A
- 52 Week Low
- HURC $13.19
- CRDL $0.77
- 52 Week High
- HURC $23.76
- CRDL $2.63
- Technical
- Relative Strength Index (RSI)
- HURC 47.35
- CRDL 39.49
- Support Level
- HURC $16.25
- CRDL $1.12
- Resistance Level
- HURC $18.45
- CRDL $1.14
- Average True Range (ATR)
- HURC 0.87
- CRDL 0.07
- MACD
- HURC -0.03
- CRDL -0.00
- Stochastic Oscillator
- HURC 49.47
- CRDL 5.56
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.